Medical News Today: All you need to know about hemarthrosis
A look at hemarthrosis, a condition where there is bleeding around the joint cavity. Here we learn more about its symptoms, treatment and causes. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 27, 2017 Category: Consumer Health News Tags: Blood / Hematology Source Type: news

Medical News Today: Vitamin K deficiency: What you need to know
The main symptom of a vitamin K deficiency is excessive bleeding caused by an inability to form blood clots. Learn about vitamin K in adults and infants. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 23, 2017 Category: Consumer Health News Tags: Nutrition / Diet Source Type: news

Your NEJM Group Today: Date Night with the EHR / Low-Dose Aspirin & Intracranial Bleeding / California FM Opportunity
Take a look at today's offering from NEJM Group: NEJM Catalyst: Infographic: Date Night with the Electronic Health Record: Two experts urge individuals and organizations... (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - December 22, 2017 Category: Primary Care Source Type: news

Novel Antithrombotics and Lower Risk of Intraocular Bleeding Novel Antithrombotics and Lower Risk of Intraocular Bleeding
Novel antithrombotics such as dabigatran or rivaroxaban are associated, in some instances, with a decreased risk of intraocular hemorrhage compared with traditional anticoagulant therapy.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 21, 2017 Category: Consumer Health News Tags: Ophthalmology News Source Type: news

Oral Agents for Cancer-Related VTE:'New Standard of Care'Oral Agents for Cancer-Related VTE:'New Standard of Care '
The oral agent rivaroxaban was as effective as subcutaneous dalteparin in controlling VTE in patients with cancer but was associated with a higher rate of bleeding.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 18, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Biom ’ Up wins FDA PMA nod for Hemoblast Bellows surgical hemostatic
Biom’Up said today it won FDA premarket approval for its Hemoblast Bellows hemostatic product designed to control bleeding during surgeries including cardiac, general and orthopedic procedures. The Paris-based company’s flagship Hemoblast Bellows product is a ready-to-use hemostatic solution that is usable several times during surgery to reduce bleeding. Approval of the hemostatic came based on results from a prospective, controlled, randomized clinical trial of 412 patients who underwent cardiothoracic, abdominal or lower limb orthopedic surgeries. Results from the trial indicated that the device met all prima...
Source: Mass Device - December 18, 2017 Category: Medical Devices Authors: Fink Densford Tags: Blood Management Food & Drug Administration (FDA) Pre-Market Approval (PMA) Regulatory/Compliance Surgical Biom'Up Source Type: news

Stunning gene therapy breakthrough driven by great dedication and graft | Robin McKie
We need more than ever to celebrate advances in medical science – though they may take years to emergeThere has been a surprising outbreak of the use of the c-word among medical researchers over the past few days. Normally cautious in their language, they have nevertheless been wielding the term “cure” when discussing the long-term potential of two separate treatments for inherited ailments that were announced last week. Such enthusiasm is striking.In one case, scientists based at St Bartholomew ’s, London – who have been working on the inherited bleeding disorder haemophilia A –outlined...
Source: Guardian Unlimited Science - December 17, 2017 Category: Science Authors: Robin McKie Tags: Medical research Science Genetics Biology Cystic fibrosis Society Huntington's disease Alzheimer's Dementia Source Type: news

Medical News Today: Internal bleeding: What you need to know
Internal bleeding or hemorrhaging is bleeding that occurs inside the body when a blood vessel is damaged. This can cause serious complications. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 16, 2017 Category: Consumer Health News Tags: Emergency Medicine Source Type: news

Medical News Today: Hemophilia cure? Gene therapy trial shows dramatic results
A year after gene therapy treatment, people with hemophilia A are showing normal levels of clotting factor and big reductions in bleeding. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 15, 2017 Category: Consumer Health News Tags: Blood / Hematology Source Type: news

FDA allows Alnylam to restart hemophilia treatment trials
(Reuters) - The U.S. Food and Drug Administration has allowed Alnylam Pharmaceuticals Inc to restart clinical trials on a drug to treat patients with a rare bleeding disorder, the company said on Friday. (Source: Reuters: Health)
Source: Reuters: Health - December 15, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

I ’m OK (sort of): The Unpredictability of OCD
When people ask me how I’m doing, I say that I’m doing ok. And sometimes I really am. The problem is that when you’re someone like me, someone who lives with Obsessive Compulsive Disorder (OCD), you’re basically ok until suddenly you’re not. Let me explain. OCD is unpredictable. It’s that schoolyard bully that sneaks up behind you to pull your pigtails just when you found a spot in the shade to sit and read your book peacefully. It’s the unpredictable storm, the one that you think has passed, only to be followed by scattered thunderstorms an hour later. It’s the questions of...
Source: Psych Central - December 14, 2017 Category: Psychiatry Authors: Rebecca Cushman Tags: Obsessive-Compulsive Disorder Personal Stories Psychology Students Treatment college coping obsessions. compulsions Ocd support worry Source Type: news

Is THIS a cure for haemophilia?
The trial, led by Barts Health NHS Trust, saw 13 patients injected with a copy of the missing gene that puts them at risk of excessive bleeding, which allowed cells to produce the missing factor. (Source: the Mail online | Health)
Source: the Mail online | Health - December 14, 2017 Category: Consumer Health News Source Type: news

40 years after first Ebola outbreak, survivors show signs they can stave off new infection
Survivors of the first known Ebola outbreak, which occurred in the Democratic Republic of the Congo in 1976, may be key to development of vaccines and therapeutic drugs to treat future outbreaks, according to a new study led by researchers at the UCLA Fielding School of Public Health.UCLA researchers located the 14 Ebola survivors of the 1976 outbreak who, in January 2016, were still living in the same small, remote villages in the forests of the Équateur Province of northwestern Democratic Republic of the Congo. The researchers obtained blood samples and health history reports from them. The data revealed evidence ...
Source: UCLA Newsroom: Health Sciences - December 14, 2017 Category: Universities & Medical Training Source Type: news

10 early signs of cancer in MEN including weight loss and bleeding
CANCER symptoms affect men more than women, but spotting them early could help survival rates. Signs of the disease include diarrhoea, weight loss and back pain. (Source: Daily Express - Health)
Source: Daily Express - Health - December 14, 2017 Category: Consumer Health News Source Type: news

Leap forward towards gene therapy cure for haemophilia A
Scientists around the world congratulate the team that has made a major advance in finding a cure for the life-threatening blood disorderScientists believe they are on the way to finding a cure for haemophilia A, the bleeding disorder that currently requires sufferers to inject themselves every other day to avoid life-threatening complications.One dose of a gene therapy given experimentally to 13 patients by NHS doctors in the UK has allowed them all to come off treatment. These were men – most sufferers are – who would not only bleed without stopping from an injury but would bleed into their joints even in the...
Source: Guardian Unlimited Science - December 14, 2017 Category: Science Authors: Sarah Boseley Health editor Tags: Science Health & wellbeing Life and style Society Source Type: news

ACC Issues Guidance for Managing Bleeds From Oral Anticoagulants ACC Issues Guidance for Managing Bleeds From Oral Anticoagulants
The report provides a"clinically applicable, easily referenced conceptual framework" to help clinicians manage bleeding complications during OAC therapy, say the authors. The ACC also has two related apps.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 13, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news

Subconjunctival Hemorrhage (Bleeding in Eye)
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - December 13, 2017 Category: General Medicine Source Type: news

ASH: Oral Edoxaban Noninferior to Dalteparin for CA - Linked VTE
Oral edoxaban found noninferior for recurrent venous thromboembolism or major bleeding (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - December 13, 2017 Category: Respiratory Medicine Tags: Internal Medicine, Oncology, Pharmacy, Pulmonology, Conference News, Source Type: news

DOACs Prevail in Cancer VTE Trials (CME/CE)
(MedPage Today) -- Bleeding data complicate efficacy benefits (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - December 12, 2017 Category: Primary Care Source Type: news

Why Spark Therapeutics stock price dropped by 40% this morning
Spark Therapeutics ’ stock price plunged more than 40 percent Monday morning after the Philadelphia-based gene therapy company provided an update of its experimental hemophilia A treatment. Preliminary clinical data showed the gene therapy treatments produced significant reductions in bleeding rates, but yielded mu ch lower increases in levels of factor VIII — the clotting protein missing in hemophilia A patients. California-based BioMarin Pharmaceutical released study results on Saturday of… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 11, 2017 Category: Pharmaceuticals Authors: John George Source Type: news

GI Bleeding With Non-Vitamin K Antagonist Oral Anticoagulants GI Bleeding With Non-Vitamin K Antagonist Oral Anticoagulants
This meta-analysis assessed the risk of GI bleeding associated with non-vitamin K antagonist oral anticoagulants as compared with conventional anticoagulation therapy.Clinical Gastroenterology and Hepatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 11, 2017 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

New therapies improve outlook for bleeding and clotting disorders
(American Society of Hematology) In three studies being presented today during the 59th American Society of Hematology (ASH) Annual Meeting and Exposition in Atlanta, researchers report remarkable benefits from new, more easily administered therapies for bleeding and clotting disorders, including hemophilia A and people with cancer experiencing venous thromboembolism. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 11, 2017 Category: International Medicine & Public Health Source Type: news

A 2nd Gene Therapy Breakthrough Against Hemophilia
Coming just days after reports of a gene therapy that pushed the bleeding disorder hemophilia B into remission, new research suggests the same could be true for adults with the "A" form of the disease. (Source: WebMD Health)
Source: WebMD Health - December 9, 2017 Category: Consumer Health News Source Type: news

Another Gene Therapy Breakthrough Against Hemophilia
Coming just days after reports of a gene therapy that pushed the bleeding disorder hemophilia B into remission, new research suggests the same could be true for adults with the "A" form of the disease. (Source: WebMD Health)
Source: WebMD Health - December 9, 2017 Category: Consumer Health News Source Type: news

Another Gene Therapy Breakthrough Against Hemophilia
SATURDAY, Dec. 9, 2017 -- Coming just days after reports of a gene therapy that pushed the bleeding disorder hemophilia B into remission, new research suggests the same could be true for adults with the " A " form of the disease. That's significant... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 9, 2017 Category: General Medicine Source Type: news

What to Do If Someone's Bleeding Badly
Source: HealthDay Related MedlinePlus Pages: Bleeding, First Aid (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - December 8, 2017 Category: Consumer Health News Source Type: news

ORBIT Bleeding Risk Score Performs Best in A - Fib
Findings based on comparison of four risk scores among atrial fibrillation patients (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - December 8, 2017 Category: Cancer & Oncology Tags: Cardiology, Family Medicine, Geriatrics, Internal Medicine, Emergency Medicine, Nursing, Oncology, Pharmacy, Pulmonology, Journal, Source Type: news

Catheter-Directed Lysis Adds Risk, Not Benefit, for Proximal DVT
(MedPage Today) -- ATTRACT trial shows no less post-thrombotic syndrome, more bleeding (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - December 8, 2017 Category: Cardiology Source Type: news

What to Do If Someone's Bleeding Badly
FRIDAY, Dec. 8, 2017 -- By knowing how to stop bleeding, you could save the life of a seriously injured person. Analysis of mass tragedies such as the Sandy Hook Elementary School shooting in 2012 revealed that many victims could have been saved if... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 8, 2017 Category: General Medicine Source Type: news

Gene Therapy Sparks Significant Factor IX Activity in 10 Men With Hemophilia B Gene Therapy Sparks Significant Factor IX Activity in 10 Men With Hemophilia B
Experimental gene therapy designed to restore production of factor IX has left all 10 hemophiliac volunteers without the need for baseline prophylaxis and halted nearly all excess bleeding, according to a December 6 online report of a small phase 1-2a study in The New England Journal of Medicine.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 8, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Study: Catheter thrombolysis doesn ’ t lower risk of post-thrombotic syndrome, raises bleeding risk
A study of catheter-guided thrombolysis in patients with deep-vein thrombosis found no reduction in risk for post-thrombotic syndrome but a higher risk of major bleeding. The study, published in the New England Journal of Medicine, examined 692 patients with acute proximal deep-vein thrombosis, randomized to receive either anticoagulation drugs alone or anticoagulation plus pharmaco-mechanical thrombolysis. The experimental arm was treated with the intra-thrombus delivery of recombinant tissue plasminogen activator and thrombus aspiration or maceration, with or without stenting. The primary outcome was ...
Source: Mass Device - December 7, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Catheters Clinical Trials peripheral Source Type: news

Gene Therapy Shows Beneficial Effect in Men With Hemophilia B
Reduction in annualized bleeding rate and in factor use with infusion of viral vector with transgene (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - December 7, 2017 Category: Cancer & Oncology Tags: Oncology, Pathology, Journal, Source Type: news

Pharmacomechanical Thrombolysis No Benefit in DVT
Addition of pharmacomechanical catheter - directed thrombolysis resulted in higher risk of bleeding (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - December 7, 2017 Category: Cancer & Oncology Tags: Internal Medicine, Emergency Medicine, Oncology, Pathology, Pulmonology, Radiology, Surgery, Journal, Source Type: news

Medical News Today: What is a epidural hematoma?
Head injuries require immediate medical attention. In some cases, a person can develop internal bleeding around the brain called an epidural hematoma. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 7, 2017 Category: Consumer Health News Tags: Emergency Medicine Source Type: news

Medical News Today: What is an epidural hematoma?
Head injuries require immediate medical attention. In some cases, a person can develop internal bleeding around the brain called an epidural hematoma. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 7, 2017 Category: Consumer Health News Tags: Emergency Medicine Source Type: news

Gene therapy makes a big advance treating hemophilia B blood disorder
Jay Konduros used to rush home several times a year after accidentally cutting or bumping himself. There he would inject himself with refrigerated blood-clotting factor to prevent internal bleeding and extensive bruising and swelling. “I was walking on eggshells all the time,” said the former aerospace engineer who has a blood disorder called hemophilia B. Then, […]Related:The moral differences between pro- and anti-vaccine parents‘The Woebot will see you now’ — the rise of chatbot therapyA woman with a transplanted uterus just gave birth — a first for the U.S. (Source: Washi...
Source: Washington Post: To Your Health - December 6, 2017 Category: Consumer Health News Source Type: news

Gene Therapy May Allow Hemophilia Patients to Go Without Meds
WEDNESDAY, Dec. 6, 2017 -- Gene therapy has helped 10 men with a form of the bleeding disorder hemophilia produce a critical blood clotting factor. This could eliminate the need for tedious and costly standard treatments, researchers report. While... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 6, 2017 Category: General Medicine Source Type: news

Jury orders Bayer, J & J to pay $28 million in Xarelto lawsuit
(Reuters) - A Philadelphia state court jury on Tuesday ordered Bayer AG and Johnson& Johnson to pay $27.8 million to an Indiana couple over the drugmakers' failure to warn of internal bleeding risks by its blockbuster drug Xarelto. (Source: Reuters: Health)
Source: Reuters: Health - December 5, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Medical News Today: Bleeding from the ear: Causes and treatments
Bleeding from the ear can be very alarming for a person. Many things can cause someone to bleed from the ear, including some emergency situations. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 4, 2017 Category: Consumer Health News Tags: Ear, Nose and Throat Source Type: news

Cardiology Experts Offer Guidance on Managing Bleeding Events in Patients on Oral Anticoagulants
The American College of Cardiology has published a guide to managing acute bleeding in patients taking direct oral anticoagulants and vitamin K antagonists. The decision... (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - December 4, 2017 Category: Primary Care Source Type: news

ACC Guides Treatment of Bleeding With Oral Anticoagulation
Pathway supports clinician decision making during management of patients with bleeding complications (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - December 2, 2017 Category: Cancer & Oncology Tags: Cardiology, Family Medicine, Geriatrics, Gastroenterology, Internal Medicine, Emergency Medicine, Neurology, Nursing, Oncology, Pharmacy, Pulmonology, Surgery, Journal, Source Type: news

Drug-Related Behavioral Issues Pose Health Risks to EMS Providers
Drug-related behavioral outbursts pose health risk to providers You and your partner are dispatched to a restroom in a public park for a 26-year-old unresponsive male. Bystanders had called 9-1-1 after finding the man. On arrival, you initially find "Patient A" obtunded, but he begins to respond as he's moved, so you and your partner can provide medical care. As he becomes more alert, the patient becomes increasingly agitated and aggressive. He begins to intentionally strike his head on the floor, causing his upper lip and mouth to bleed. Attempting to load him onto the stretcher, he bites your part...
Source: JEMS Operations - December 1, 2017 Category: Emergency Medicine Authors: Christine McGuire-Wolfe, PhD, CIC, CPH, EMT-P Tags: Operations Source Type: news

Drug-Related Behavioral Issues Pose Health Risks to EMS Providers
Drug-related behavioral outbursts pose health risk to providers You and your partner are dispatched to a restroom in a public park for a 26-year-old unresponsive male. Bystanders had called 9-1-1 after finding the man. On arrival, you initially find "Patient A" obtunded, but he begins to respond as he's moved, so you and your partner can provide medical care. As he becomes more alert, the patient becomes increasingly agitated and aggressive. He begins to intentionally strike his head on the floor, causing his upper lip and mouth to bleed. Attempting to load him onto the stretcher, he bites your partner's finger, ...
Source: JEMS Operations - December 1, 2017 Category: Emergency Medicine Authors: Christine McGuire-Wolfe, PhD, CIC, CPH, EMT-P Tags: Operations Source Type: news

Genentech selects ARJ Infusion Services as pharmacy partner on new...
Hemlibra product reduces bleeding episodes in hemophilia A patients with inhibitors(PRWeb December 01, 2017)Read the full story at http://www.prweb.com/releases/2017/12/prweb14971636.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - December 1, 2017 Category: Pharmaceuticals Source Type: news

U.S. troops get freeze-dried plasma for use on the battlefield
The plasma helps clot blood and can prevent badly wounded troops from bleeding to death on the battlefield (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - November 30, 2017 Category: Consumer Health News Source Type: news

Slimmers warned of dangers of online weight loss pills
Banned ingredients cause diarrhoea, bleeding, blurred vision and heart problems Related items fromOnMedica Managing obesity in primary care - Part 2 Managing obesity in primary care - Part 1 Largest recorded seizure of fake medicines announced Viagra now available from a pharmacy without a prescription Regulator cracks down on unsafe practice at online pharmacies (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 30, 2017 Category: UK Health Source Type: news

Real-world Study Reassures on Dabigatran Stroke, ICH Rates Real-world Study Reassures on Dabigatran Stroke, ICH Rates
But results confirm gastrointestinal bleeding risk, particularly in the elderly and those with renal failure, and questions over the MI risk still remain.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 29, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Lobachevsky University scientists launch the production of a unique hemostatic agent
(Lobachevsky University) The development of the unique agent called Tectum, which accelerates blood coagulation in a matter of seconds, is nearing completion: scientists of Lobachevsky University are planning to launch in Nizhny Novgorod the production of this unique means for stopping bleeding.Tectum is a medical product rather than medical drug, since it has no systemic effect on the body and fulfills a local function. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 29, 2017 Category: International Medicine & Public Health Source Type: news

GE partners with MedyMatch on AI
GE Healthcare is partnering with artificial intelligence (AI) developer MedyMatch...Read more on AuntMinnie.comRelated Reading: NVIDIA, GE expand partnership to focus on AI GE partners with Intel on digital imaging DiA Imaging Analysis partners with GE Samsung NeuroLogica, MedyMatch to collaborate MedyMatch debuts AI for detecting intracranial bleeding (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 28, 2017 Category: Radiology Source Type: news

Understanding a therapeutic paradox for treating thrombo-vascular complications in kidney disease
(Boston University School of Medicine) Researchers at Boston University School of Medicine (BUSM) have discovered a potential treatment target to prevent chronic kidney disease patients from developing blood clots without causing bleeding complications - an unwanted and perplexing side effect. They say the strategy offers a much-needed therapeutic alternative to standard-of-care heparin, which throws off the finely-tuned balance between pro-clotting and anticoagulant factors in blood vessels that work to keep fluid flowing while protecting against excessive bleeding after injuries. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 28, 2017 Category: International Medicine & Public Health Source Type: news